BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 38584803)

  • 1. Mitigating disparity?: Treatment patterns, survival, and recurrence rates by race, ethnicity, and hospital site across a large urban health system.
    Papatla K; Orfanelli T; Stoffels G; Layne T; Baldwin E; Leibold A; Blank SV; Cohen S
    Gynecol Oncol Rep; 2024 Jun; 53():101372. PubMed ID: 38584803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
    Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
    Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in survival among women with endometrial cancer in an equal access system.
    Park AB; Darcy KM; Tian C; Casablanca Y; Schinkel JK; Enewold L; McGlynn KA; Shriver CD; Zhu K
    Gynecol Oncol; 2021 Oct; 163(1):125-129. PubMed ID: 34325938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
    Rodriguez VE; LeBrón AMW; Chang J; Bristow RE
    Cancer; 2021 Jul; 127(14):2423-2431. PubMed ID: 33721357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma: A Pooled Data Analysis.
    Patrich T; Wang Y; Elshaikh MA; Zhu S; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Taunk NK; Chino J; Russo AL; Lea JS; Lee LJ; Albuquerque KV; Hathout L
    Am J Clin Oncol; 2023 Mar; 46(3):114-120. PubMed ID: 36625449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and ethnic differences in type II endometrial cancer mortality outcomes: The contribution of sociodemographic, clinicopathologic, and treatment factors.
    Karia PS; Huang Y; Tehranifar P; Wright JD; Genkinger JM
    Gynecol Oncol; 2023 Jan; 168():119-126. PubMed ID: 36434946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of obesity with type I uterine cancer-is this an oversimplification?
    Eakin CM; Liao CI; Salani R; Cohen JG; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2022 Sep; 227(3):538-539. PubMed ID: 35562051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype.
    Clarke MA; Devesa SS; Hammer A; Wentzensen N
    JAMA Oncol; 2022 Jun; 8(6):895-903. PubMed ID: 35511145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer statistics for African American/Black People 2022.
    Giaquinto AN; Miller KD; Tossas KY; Winn RA; Jemal A; Siegel RL
    CA Cancer J Clin; 2022 May; 72(3):202-229. PubMed ID: 35143040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study.
    Arend RC; Goel N; Roane BM; Foxall ME; Dholakia J; Londoño AI; Wall JA; Leath CA; Huh WK
    Gynecol Oncol; 2021 Oct; 163(1):85-92. PubMed ID: 34372972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine serous carcinoma: key advances and novel treatment approaches.
    Ferriss JS; Erickson BK; Shih IM; Fader AN
    Int J Gynecol Cancer; 2021 Aug; 31(8):1165-1174. PubMed ID: 34210768
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.